Dow Down 0.32% Nasdaq Down 0.62%

Alexion Pharmaceuticals, Inc. (ALXN)

-NasdaqGS
139.28 Down 3.25(2.28%) 4:00PM EDT
|After Hours : 139.28 0.00 (0.00%) 5:40PM EDT
Prev Close:142.53
Open:141.88
Bid:128.00 x 200
Ask:143.32 x 100
1y Target Est:197.21
Beta:1.42705
Earnings Date:Jul 28 - Aug 1 (Est.)
Day's Range:137.40 - 142.30
52wk Range:124.16 - 208.88
Volume:2,051,577
Avg Vol (3m):1,803,580
Market Cap:31.30B
P/E (ttm):207.88
EPS (ttm):0.67
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ALXNDown 2.28%31.30B
AMGNDown 1.41%118.73B
BAXDown 0.09%24.33B

Key Statistics

Forward P/E (1 yr):20.91
P/S (ttm):12.33
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :5.11
Quarterly EPS Est (Jun-16) :1.21
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.37

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback